Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

March 7, 2023 7:39 AM 2 min read

DocuSign To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday

by Lisa Levin Benzinga Editor

Follow

ArticleFeaturedTickersList12345!!!

Check This Out: Insiders Selling Moderna, Hayward Holdings And 2 Other Stocks

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Posted In:

News Price Target Small Cap Pre-Market Outlook Markets Analyst Ratings Trading Ideas analyst forecasts PT Changes

ACRSAclaris Therapeutics Inc

CCOICogent Communications Holdings Inc

DOCUDocusign Inc

ESPREsperion Therapeutics Inc

GWREGuidewire Software Inc

LNGCheniere Energy Inc

MRKMerck & Co Inc

TCOMTrip.com Group Ltd

Wells Fargo cut the price target for Cheniere Energy, Inc. (NYSE:LNG) from $236 to $230. Wells Fargo analyst Michael Blum maintained an Overweight rating. Cheniere Energy shares fell 4.8% to close at $156.55 on Monday.
RBC Capital raised the price target for Cogent Communications Holdings, Inc. (NASDAQ:CCOI) from $61 to $69. RBC Capital analyst Bora Lee maintained an Outperform rating on the stock. Cogent Communications shares fell 0.2% to close at $63.96 on Monday.
Mizuho lifted the price target for Trip.com Group Limited (NASDAQ:TCOM) from $45 to $49. Mizuho analyst James Lee maintained a Buy rating. Trip.com shares fell 0.3% to close at $38.61 on Monday.
BTIG cut the price target for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) from $32 to $29. BTIG analyst Julian Harrison maintained a Buy rating. Aclaris Therapeutics shares fell 2.4% to $6.90 in pre-market trading.
Needham cut Cara Therapeutics, Inc. (NASDAQ:CARA) price target from $26 to $22. Needham analyst Joseph Stringer maintained a Buy rating. Cara Therapeutics shares fell 27.6% to $7.25 in pre-market trading.
Barclays raised Ciena Corporation (NYSE:CIEN) price target from $71 to $74. Barclays analyst Tim Long maintained an Overweight rating. Ciena shares rose 0.7% to $51.25 in pre-market trading.
Evercore ISI Group increased Linde plc (NYSE:LIN) price target from $355 to $375. Evercore ISI Group analyst Stephen Richardson maintained an Outperform rating. Linde shares fell 0.9% to $354.83 in pre-market trading.
Atlantic Equities raised Merck & Co., Inc. (NYSE:MRK) price target from $122 to $127. Atlantic Equities analyst Steve Chesney maintained an Overweight rating. Merck shares rose 0.1% to $111.12 in pre-market trading.
Credit Suisse raised Esperion Therapeutics, Inc. (NASDAQ:ESPR) price target from $6.5 to $7. Credit Suisse analyst Judah Frommer upgraded the stock from Underperform to Neutral. Esperion Therapeutics shares fell 0.1% to $5.07 in pre-market trading.
Jefferies raised DocuSign, Inc. (NASDAQ:DOCU) price target from $70 to $80. Jefferies analyst Brent Thill maintained a Buy rating. DocuSign shares fell 1.4% to close at $64.15 on Monday.
Wells Fargo raised Guidewire Software, Inc. (NYSE:GWRE) price target $55 to $60. Wells Fargo analyst Michael Turrin maintained an Underweight rating. Guidewire Software shares fell 2.3% to close at $71.52 on Monday.

ACRSAclaris Therapeutics Inc

CCOICogent Communications Holdings Inc

DOCUDocusign Inc

ESPREsperion Therapeutics Inc

GWREGuidewire Software Inc

LNGCheniere Energy Inc

MRKMerck & Co Inc

TCOMTrip.com Group Ltd

Comments

Loading...